CCN3 administration after surgically induced myocardial infarction. CCN3 administration after surgically induced myocardial infarction

CCN3 administration after surgically induced myocardial infarction Overall design: After surgically ligating the left anterior descending artery, mice were administered recombinant human CCN3 at a concentration of 6 µg/kg or PBS as a control by intraperitoneal injection daily for four days. Left ventricles of were collected after four days and total RNA was extracted by via Trizol. Three biological replicates were assessed per group.